Tourmaline expects to pay CA$750 million over the next years in base dividends. See more on TRMLF's expansion plans, higher ...
In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...
The recent findings on consanguinity rates in Sri Lanka by Dr. Thurairajah’s team, as reported in The Sunday Times, have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback